Diagnosis and Treatment of Major Depressive Disorder


Science & Innovation Theater Webinar 


Diagnosis and Treatment of Major Depressive Disorder
Takeda Pharmaceuticals U.S.A, Inc.

Thursday, December 14, 2017, 2-3pm, EST 

The information contained in this webinar is intended for US payers. 

Major depressive disorder (MDD) is a prevalent, often burdensome condition with a heterogeneous population of patients who may present with a variety of symptoms. This program will review the diagnostic criteria and current treatment guidelines for MDD. Treatment considerations for a current option for MDD will be portrayed through the patient experience by addressing patient questions around short- and long-term efficacy, mechanism of action, safety and tolerability, and affordability.

This webinar is supported, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy. 

Sponsored by:  

   Takeda logo(1) 

** IMPORTANT: AMCP webinars are limited to the first 500 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.